HPGC Renmintongtai Pharmaceutical Corp - ESG Rating & Company Profile powered by AI
Detailed ESG assessment of HPGC Renmintongtai Pharmaceutical Corp can be accessed by signing up for free. Alternative corporations in the scoring peer group for HPGC Renmintongtai Pharmaceutical Corp are shown below. Browse to the end of this webpage for potential risks for HPGC Renmintongtai Pharmaceutical Corp based on sector, location and marketcap.
HPGC Renmintongtai Pharmaceutical Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | HPGC Renmintongtai Pharmaceutical Corp | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does HPGC Renmintongtai Pharmaceutical Corp have an accelerator or VC vehicle to help deliver innovation?
Does HPGC Renmintongtai Pharmaceutical Corp disclose current and historical energy intensity?
Does HPGC Renmintongtai Pharmaceutical Corp report the average age of the workforce?
Does HPGC Renmintongtai Pharmaceutical Corp reference operational or capital allocation in relation to climate change?
Does HPGC Renmintongtai Pharmaceutical Corp disclose its ethnicity pay gap?
Does HPGC Renmintongtai Pharmaceutical Corp disclose cybersecurity risks?
Does HPGC Renmintongtai Pharmaceutical Corp offer flexible work?
Does HPGC Renmintongtai Pharmaceutical Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does HPGC Renmintongtai Pharmaceutical Corp disclose the number of employees in R&D functions?
Does HPGC Renmintongtai Pharmaceutical Corp conduct supply chain audits?
Does HPGC Renmintongtai Pharmaceutical Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does HPGC Renmintongtai Pharmaceutical Corp conduct 360 degree staff reviews?
Does HPGC Renmintongtai Pharmaceutical Corp disclose the individual responsible for D&I?
Does HPGC Renmintongtai Pharmaceutical Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does HPGC Renmintongtai Pharmaceutical Corp disclose current and / or historical scope 2 emissions?
Does HPGC Renmintongtai Pharmaceutical Corp disclose water use targets?
Does HPGC Renmintongtai Pharmaceutical Corp have careers partnerships with academic institutions?
Did HPGC Renmintongtai Pharmaceutical Corp have a product recall in the last two years?
Does HPGC Renmintongtai Pharmaceutical Corp disclose incidents of discrimination?
Does HPGC Renmintongtai Pharmaceutical Corp allow for Work Councils/Collective Agreements to be formed?
Has HPGC Renmintongtai Pharmaceutical Corp issued a profit warning in the past 24 months?
Does HPGC Renmintongtai Pharmaceutical Corp disclose parental leave metrics?
Does HPGC Renmintongtai Pharmaceutical Corp disclose climate scenario or pathway analysis?
Does HPGC Renmintongtai Pharmaceutical Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does HPGC Renmintongtai Pharmaceutical Corp disclose the pay ratio of women to men?
Does HPGC Renmintongtai Pharmaceutical Corp support suppliers with sustainability related research and development?
Does HPGC Renmintongtai Pharmaceutical Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does HPGC Renmintongtai Pharmaceutical Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is HPGC Renmintongtai Pharmaceutical Corp involved in embryonic stem cell research?
Does HPGC Renmintongtai Pharmaceutical Corp disclose GHG and Air Emissions intensity?
Does HPGC Renmintongtai Pharmaceutical Corp disclose its waste policy?
Does HPGC Renmintongtai Pharmaceutical Corp report according to TCFD requirements?
Does HPGC Renmintongtai Pharmaceutical Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does HPGC Renmintongtai Pharmaceutical Corp disclose energy use targets?
Does HPGC Renmintongtai Pharmaceutical Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does HPGC Renmintongtai Pharmaceutical Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for HPGC Renmintongtai Pharmaceutical Corp
These potential risks are based on the size, segment and geographies of the company.
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.